Loading resource…

University of Western Australia
Inclusion body myositis is characterized by slowly progressing muscular weakness and atrophy, with a distinctive pattern of muscle involvement. The aetiology and pathogenesis remain poorly understood, although genetic factors, ageing, and environmental triggers may play a role. The document discusses various treatment approaches, including the efficacy of immunotherapy and other therapeutic options, while highlighting the challenges in managing this condition.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Traumatic Brain Injury
Same clinical topic · Neurology

Classification of the Epilepsies
Same clinical topic · Neurology

Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Same clinical topic · Neurology

An update on management of subarachnoid haemorrhage
Same clinical topic · Neurology

INCLUSION BODY MYOSITIS
Same clinical topic · Neurology

ENCEPHALITIS
Same clinical topic · Neurology

INTRACEREBRAL HAEMORRHAGE
Same clinical topic · Neurology

INCLUSION BODY MYOSITIS
Same clinical topic · Neurology

PREVENTION OF STROKE
Same clinical topic · Neurology